Association of Life's Simple 7 with incident cardiovascular disease in 52,956 patients with cancer.
Hidehiro KanekoYuta SuzukiKensuke UenoAkira OkadaKatsuhito FujiuSatoshi MatsuokaNobuaki MichihataTaisuke JoNorifumi TakedaHiroyuki MoritaKentaro KamiyaKoichi NodeHideo YasunagaIssei KomuroPublished in: European journal of preventive cardiology (2022)
Life's Simple 7 could be applicable for CVD risk stratification even among cancer survivors. Optimizing Life's Simple 7 may prevent the development of CVD in cancer survivors.